Kinins IV pp 405-410 | Cite as

Synthetic Inhibitors of Carboxypeptidase N

  • George H. Fisher
  • James W. Ryan
  • Alfred Chung
  • Thomas H. PlummerJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 198A)


Further to explore the functions of carboxypeptidase N (CPN) in vivo, we undertook two studies to find CPN inhibitors of high potency and relatively long duration of action. In each study we examined for inhibition of hydrolysis of [3H] benzoyl-Ala-Arg using pure bovine serum CPN or human serum. In the first such study we synthesized a series of acyl amino acids and acyl di - and tripeptides containing arginine, lysine or both. All proved to be weak inhibitors (Ki = 10-3 to 10-4 M). Nα-carbamoyl-Arg was the strongest: Ki = 3.5 × 10-5 M.

In the second study we prepared S-acyl (thio ester) derivatives of the highly potent CPN inhibitor 2-mercaptomethyl-3-guanidinoethylthiopropionic acid (2-MGP), as certain S-acyl groups markedly increase the duration of captopril, another mercapto-containing compound. Acetyl-, Boc-phenylalanyl- phenylalanyl-, benzoyl-alanyl-, alanyl-, and Boc-alanyl-2-MGP retained the high potency of 2-MGP in vitro. Although Ala-2-MGP exerted maximum effects in vivo, like those of 2-MGP, the duration of action of Ala-2-MGP was slightly shorter than that of 2-MGP. These results indicate that the mercapto group of 2-MGP can be taken up in some forms of thioester linkage and still retain virtually the full potency of 2-MGP itself. Thus, it appears that a free mercapto function is not essential for the action of 2-MGP.


Angiotensin Converting Enzyme Maleic Anhydride Acyl Derivative Mercapto Group Catalytic Hydrogenolysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ryan, J.W. and Ryan, U.S., Endothelial Surface Enzymes and the Dynamic Processing of Plasma Substrates. Intl. Rev. Exp. Pathol. 26: 1–43 (1984).Google Scholar
  2. 2.
    Huey, R., Bloor, C.M., Kawahara, M.S. and Hugli, T.E., Potentiation of the Anaphylatoxins in vivo Using an Inhibitor of Serum Carboxypepti dase N. I. Lethality and Pathologic Effect on Pulmonary Tissue. Amer. J. Pathol. 112: 48–60 (1983).Google Scholar
  3. 3.
    Ryan, J.W., Berryer, P., Hart, M.A. and Ryan, U.S., Aggregate Anaphylaxis and Carboxypeptidase N. This Meeting. (1984).Google Scholar
  4. 4.
    Plummer, T.H. and Ryan, T.J., A Potent Mercapto Bi-Product Analogue Inhibitor for Human Carboxypeptidase N. Biochem. Biophys. Res. Commun. 98: 448–454 (1981).CrossRefGoogle Scholar
  5. 5.
    Chauhan, V.S., Young, G.T. and Bowery, N.G., Structure-Activity Studies in the Bradykinin Series: Synthesis of Analogs Modified in Position. Bioorg. Chem. 8: 333–338 (1979).CrossRefGoogle Scholar
  6. 6.
    Sheehan, J.C. and Yang, D.-D.H., Use of N-Formyl Amino Acids in Peptide Synthesis. J. Amer. Chem. Soc. 80: 1154–1158 (1958).CrossRefGoogle Scholar
  7. 7.
    Ryan, J.W., Chung, A. and Ryan, U.S., A Radioassay for Carboxypeptidase N. Adv. Exp. Med. Biol. 156B: 867–874 (1983).Google Scholar
  8. 8.
    Ryan, J.W., Angiotensin I Converting Enzyme (Kininase II). In: Methods of Enzymatic Analysis, vol. V, Enzymes 3: Peptidases, Proteases and Their Inhibitors, Ed. by Bergmeyer, Verlag Chemie, Weinheim, 20–34 (1984).Google Scholar
  9. 9.
    Carlin, G., Ryan, J.W. and Saldeen, T., Assays of Components of the Kallikrein-Kinin System Based on First Order Reaction Kinetics. Adv. Exp. Med. Biol. 156B: 797–804 (1983).PubMedGoogle Scholar
  10. 10.
    Soffer, R.L., Angiotensin Converting Enzyme and the Regulation of Vasoactive Peptides. Ann. Rev. Biochem. 45: 73–94 (1976).CrossRefGoogle Scholar
  11. 11.
    Plummer, T.H. and Hurwitz, M., Human Plasma Carboxypeptidase N: Isolation and Characterization. J. Biol. Chem. 253: 3907–3912 (1978).PubMedGoogle Scholar
  12. 12.
    Cushman, D.W., Cheung, H.S., Sabo, E.F. and Ondetti, M.A., Design of Potent Competitive Inhibitors of Angiotensin-Converting Enzyme. Carboxyalkanoyl and Mercaptoalkanoyl Amino Acids. Biochemistry 16: 5484–5491 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    Ryan, J.W. and Chung, A., A New Class of Inhibitors of Angiotensin Converting Enzyme. Adv. Exp. Med. Biol. 156B: 1133–1139 (1983).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • George H. Fisher
    • 1
  • James W. Ryan
    • 1
  • Alfred Chung
    • 1
  • Thomas H. PlummerJr.
    • 2
  1. 1.Department of MedicineUniversity of Miami School of MedicineMiamiUSA
  2. 2.Center for Laboratories and ResearchNew York State Department of HealthAlbanyUSA

Personalised recommendations